MENU
APLS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Apellis Pharmaceuticals (APLS) Earnings Date & Reports

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade... Show more

A.I. Advisor
published Earnings

APLS is expected to report earnings to rise 17.97% to -34 cents per share on May 01

Apellis Pharmaceuticals APLS Stock Earnings Reports
Q1'25
Est.
$-0.34
Q4'24
Beat
by $0.08
Q3'24
Missed
by $0.17
Q2'24
Beat
by $0.01
Q1'24
Missed
by $0.07
The last earnings report on February 28 showed earnings per share of -28 cents, beating the estimate of -37 cents. With 2.67M shares outstanding, the current market capitalization sits at 2.89B.
View a ticker or compare two or three
APLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapeutics and drug delivery technologies to address chronic inflammatory diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Distributors
Address
100 Fifth Avenue
Phone
+1 617 977-5700
Employees
706
Web
https://www.apellis.com